Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer
Weilong Zou,
Zhanjie Fang,
Yu Feng,
Shangjin Gong,
Ziqiang Li,
Meng Li,
Yong Sun,
Xiuyan Ruan,
Xiangdong Fang,
Hongzhu Qu,
Haiyang Li
Affiliations
Weilong Zou
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University
Zhanjie Fang
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Yu Feng
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University
Shangjin Gong
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Ziqiang Li
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University
Meng Li
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Yong Sun
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University
Xiuyan Ruan
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Xiangdong Fang
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Hongzhu Qu
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation
Haiyang Li
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University
Abstract Background Patients with primary multifocal hepatocellular carcinoma (HCC) have a poor prognosis and often experience a high rate of treatment failure. Multifocal HCC is mainly caused by intrahepatic metastasis (IM), and though portal vein tumor thrombosis (PVTT) is considered a hallmark of IM, the molecular mechanism by which primary HCC cells invade the portal veins remains unclear. Therefore, it is necessary to recognize the early signs of metastasis of HCC to arrange better treatment for patients. Results To determine the differential molecular features between primary HCC with and without phenotype of metastasis, we used the CIBERSORTx software to deconvolute cell types from bulk RNA-Seq based on a single-cell transcriptomic dataset. According to the relative abundance of tumorigenic and metastatic hepatoma cells, VEGFA + macrophages, effector memory T cells, and natural killer cells, HCC samples were divided into five groups: Pro-T, Mix, Pro-Meta, NKC, and MemT, and the transcriptomic and genomic features of the first three groups were analyzed. We found that the Pro-T group appeared to retain native hepatic metabolic activity, whereas the Pro-Meta group underwent dedifferentiation. Genes highly expressed in the group Pro-Meta often signify a worse outcome. Conclusions The HCC cohort can be well-typed and prognosis predicted according to tumor microenvironment components. Primary hepatocellular carcinoma may have obtained corresponding molecular features before metastasis occurred.